Capecitabine,Carboplatin,Cisplatin
Not Tagged
['tnbc']
dr. olga kantor ( ) with her excellent #asco23 poster on disease outcomes by race in patients with high-risk #tnbc with residual disease after neoadjuvant chemotherapy: a post-hoc analysis of the ea1131 randomized clinical trial. 
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425